Analysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence

PURPOSE: Real-time detection and intervention can be used as potential measures to markedly decrease breast cancer mortality. Assessment of circulating tumor DNA (ctDNA) may offer great benefits for the management of breast cancer over time. However, the use of ctDNA to predict the effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Shuai, Tian, Wuguo, Zhao, Jianjie, Chen, Yi, Zhang, Xiaohua, Gao, Bo, He, Yujun, Luo, Donglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462818/
https://www.ncbi.nlm.nih.gov/pubmed/32908788
http://dx.doi.org/10.4048/jbc.2020.23.e41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462818/
https://www.ncbi.nlm.nih.gov/pubmed/32908788
http://dx.doi.org/10.4048/jbc.2020.23.e41

Ejemplares similares